Related Experiment Video
Updated: May 5, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
HOMA-IR Index and Pediatric Psoriasis Severity-A Retrospective Observational Study
Adelina Maria Sendrea1,2,3, Denis Iorga4, Mihai Dascalu4,5
1Pediatric Dermatology Department, Carol Davila University of Medicine and Pharmacy, 8 Eroilor Sanitari Boulevard, 050474 Bucharest, Romania.
This study found no link between insulin resistance and psoriasis severity in children. However, nail pitting showed a potential, though not statistically significant, association with insulin resistance.
Area of Science:
- Pediatric Dermatology
- Metabolic Syndrome
- Inflammatory Diseases
Background:
- Psoriasis is a chronic inflammatory condition with systemic implications.
- Insulin resistance is linked to adult psoriasis severity, but data in children is scarce.
Purpose of the Study:
- To investigate the association between insulin resistance (HOMA-IR) and psoriasis severity (PASI) in pediatric patients.
- To explore other potential relationships within the dataset.
Main Methods:
- Retrospective analysis of 43 children with various psoriasis types.
- Calculation of Homeostatic Model Assessment for Insulin Resistance (HOMA-IR).
- Assessment of Psoriasis Area and Severity Index (PASI) scores.
Main Results:
- No significant association was found between HOMA-IR and PASI (p=0.512).
- A potential link between nail pitting and insulin resistance was observed (p=0.038), but likely a false positive.
- Significant associations were noted between HOMA-IR and BMI (p=0.001), PASI and quality of life (p=0.005), and psoriasis severity and type (p=0.001).
Conclusions:
- The null hypothesis that insulin resistance is not positively associated with psoriasis severity in children cannot be rejected.
- Further studies are needed to confirm pilot findings on insulin resistance and pediatric psoriasis.
More Related Videos
Related Concept Videos
Documentation in Long-Term and Home Healthcare Setting
Long-Term Care Facilities
Nephrotic Syndrome II : Assessment and Medical Management
Asthma III: Clinical Manifestations

